Cargando…
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314516/ https://www.ncbi.nlm.nih.gov/pubmed/35779224 http://dx.doi.org/10.1007/s40744-022-00470-9 |
| _version_ | 1784754335712804864 |
|---|---|
| author | Schett, Georg Loza, Matthew J. Palanichamy, Arumugam FitzGerald, Oliver Ritchlin, Christopher Bay-Jensen, Anne-Christine Nielsen, Signe Holm Gao, Sheng Hsia, Elizabeth C. Kollmeier, Alexa P. Xu, Xie L. Baribaud, Frédéric Sweet, Kristen |
| author_facet | Schett, Georg Loza, Matthew J. Palanichamy, Arumugam FitzGerald, Oliver Ritchlin, Christopher Bay-Jensen, Anne-Christine Nielsen, Signe Holm Gao, Sheng Hsia, Elizabeth C. Kollmeier, Alexa P. Xu, Xie L. Baribaud, Frédéric Sweet, Kristen |
| author_sort | Schett, Georg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9314516 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93145162022-07-27 Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) Schett, Georg Loza, Matthew J. Palanichamy, Arumugam FitzGerald, Oliver Ritchlin, Christopher Bay-Jensen, Anne-Christine Nielsen, Signe Holm Gao, Sheng Hsia, Elizabeth C. Kollmeier, Alexa P. Xu, Xie L. Baribaud, Frédéric Sweet, Kristen Rheumatol Ther Publisher Correction Springer Healthcare 2022-07-02 /pmc/articles/PMC9314516/ /pubmed/35779224 http://dx.doi.org/10.1007/s40744-022-00470-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Publisher Correction Schett, Georg Loza, Matthew J. Palanichamy, Arumugam FitzGerald, Oliver Ritchlin, Christopher Bay-Jensen, Anne-Christine Nielsen, Signe Holm Gao, Sheng Hsia, Elizabeth C. Kollmeier, Alexa P. Xu, Xie L. Baribaud, Frédéric Sweet, Kristen Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title | Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title_full | Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title_fullStr | Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title_full_unstemmed | Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title_short | Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) |
| title_sort | publisher correction to: collagen turnover biomarkers associate with active psoriatic arthritis and decrease with guselkumab treatment in a phase 3 clinical trial (discover-2) |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314516/ https://www.ncbi.nlm.nih.gov/pubmed/35779224 http://dx.doi.org/10.1007/s40744-022-00470-9 |
| work_keys_str_mv | AT schettgeorg publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT lozamatthewj publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT palanichamyarumugam publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT fitzgeraldoliver publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT ritchlinchristopher publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT bayjensenannechristine publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT nielsensigneholm publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT gaosheng publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT hsiaelizabethc publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT kollmeieralexap publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT xuxiel publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT baribaudfrederic publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 AT sweetkristen publishercorrectiontocollagenturnoverbiomarkersassociatewithactivepsoriaticarthritisanddecreasewithguselkumabtreatmentinaphase3clinicaltrialdiscover2 |